I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Botulinum neurotoxin (BoNT) as the most potent biological toxin has been effectively used both therapeutically and cosmetically for a wide range of disorders in various of medical conditions.\[[@ref1]\] Bibliometrics is the evaluation of scientific literature in a certain field in an all-inclusive manner.\[[@ref2]\] Although there has been a rising popularity of bibliometric and scientometric assessment of the scientific data, the medical literature lacks a study investigating bibliometric features of the articles related to BoNT. In this study, we aimed to perform a detailed bibliometric evaluation of botulinum toxin literature and generated a trend analysis in this popular area.

S[UBJECTS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
================================================

All the documents published between 1975 and 2017 including "*botulinum toxin*" and "*botulinum neurotoxin*," and commercial brand names of BoNT products such as "*botox*," "*dysport*," and "*xeomin*" were analyzed in this study. All data used in our study were retrieved from four databases (Web of Science Core Collection, Russian Science Citation Index, SciELO Citation Index, and Korean Journal Database) provided by Web of Science (WoS) (Thomson Reuters, New York). All articles published in 2018 were excluded. Articles published from Wales, England, Scotland, and Northern Ireland were evaluated under the United Kingdom main title. The "*China*" main heading was used for the articles from People's Republic of China and the mainland of China. Documents from Germany, West Germany, East Germany, and Federal Republic of Germany were united under "*Germany*" main heading. We performed statistical analyses using SPSS (version 22.0, SPSS Inc., Chicago, IL; licensed for Hitit University, Çorum, Turkey). Spearman's correlation coefficient analysis was used to investigate a possible correlation between publication numbers and citations of the literature. A value of *P \<* 0.05 was accepted as statistically significant. We created infographics revealing world distribution density of botulinum toxin literature using GunnMap free software and Microsoft Excel (Microsoft Corporation, Redmond, Washington).\[[@ref3]\] We created bibliometric network maps showing the most used keywords, and relationships and connection of the countries and the institutions. Bibliometric network visualization maps were generated by using VOSviewer resource freeware (Centre for Science and Technology Studies, Leiden University, Leiden, The Netherlands) in our study.\[[@ref4]\]

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Total number of publications {#sec2-1}
----------------------------

As we searched four databases, a total of 24,948 documents were found and 82.43% of which was in the WoS Core Collection. It was noted that 5,688 items were open access. Most of the documents were original articles (*n* = 19,009; 76.19%). Other most published document types were abstracts, reviews, and meeting reports (17.88%, 17.44%, and 14.4%, respectively) \[[Table 1](#T1){ref-type="table"}\]. The United States was the leading country in the literature with 8,729 items (34.29%) followed by the United Kingdom, Germany, and Italy (14.61%, 11.18%, and 5.5%, respectively) \[[Figure 1](#F1){ref-type="fig"}\]. All top 10 countries ranked by total publication number were developed countries \[[Figure 2](#F2){ref-type="fig"}\].

###### 

Document types in scientific literature related to botulinum toxin published between 1975 and 2017

  Document type           Number^a^    \%^a^
  ----------------------- ------------ ---------
  Original article        19,009       76.19
  Abstract                4,461        17.88
  Review                  4,352        17.44
  Meeting                 3,592        14.4
  Case Report             1,859        7.45
  Clinical Trial          1,692        6.78
  Letter                  1,258        5.04
  Editorial               1,025        4.11
  News                    98           0.39
  Correction              95           0.38
  Book                    75           0.3
  Reference Material      68           0.27
  Biography               19           0.08
  Bibliography            8            0.03
  Report                  7            0.03
  Retracted Publication   5            0.02
  Retraction              4            0.02
  Other                   8,352        33.48
  **Total**               **24,948**   **100**

^a^Total number may exceed the number of the publications in this field and total percentages may exceed 100% because certain items were included in more than one category

![Top 10 countries publishing botulinum toxin publications by total number of documents](JCAS-13-95-g001){#F1}

![Global publication density on botulinum toxin between 1975 and 2017](JCAS-13-95-g002){#F2}

Productivity {#sec2-2}
------------

We calculated a productivity score for each country publishing academic documents. We measured the score with a formula published previously in the literature (total production number of country/population × 1,000,000). The United Kingdom ranked first with the highest productivity score (55.09) followed by Switzerland, Denmark, and Germany (47.7, 34.01, and 33.98, respectively). The United States which ranked 1 in literature (34.29%) with the total publication number was 8 in this ranking \[[Figure 3](#F3){ref-type="fig"}\].

![The most productive 10 countries on botulinum toxin literature between 1975 and 2017](JCAS-13-95-g003){#F3}

Research areas, authors, journals, and institutions {#sec2-3}
---------------------------------------------------

Neurology, pharmacology, and biochemistry were found to be the most studied areas in the literature related to BoNT (56.51%, 56.12%, and 47.16%) \[[Table 2](#T2){ref-type="table"}\]. Aktories was detected to be the most productive author with 235 articles (0.94%) followed by Jankovic and Dressler (0.69% and 0.65%) \[[Table 3](#T3){ref-type="table"}\]. All top 10 authors were from developed countries. University of California System was noted to be the most productive institution with 708 items (3%). All institutions were from developed countries \[[Table 4](#T4){ref-type="table"}\]. *Movement Disorders* was the leading journal in botulinum toxin literature and covered 3.34% of all documents followed by *Neurology* and *Toxicon* (2.08% and 1.99%, respectively) \[[Table 5](#T5){ref-type="table"}\].

###### 

The first 10 research areas of the publications related to botulinum toxin

  Research areas                   Number of publications^a^   \%^a^
  -------------------------------- --------------------------- -------
  Neurosciences/neurology          13,348                      56.51
  Pharmacology/pharmacy            13,256                      56.12
  Biochemistry/molecular biology   11,141                      47.16
  Toxicology                       9,453                       40.02
  Surgery/plastic surgery          4,459                       18.88
  Physiology                       3,705                       15.68
  Anatomy/morphology               3,644                       15.43
  Infectious diseases              3,406                       14.42
  Behavioral sciences              2,861                       12.11
  Geriatrics/gerontology           2,858                       12.1

^a^Total number may exceed the number of the publications in this field, and total percentages may exceed 100% because certain items were included in more than one category

###### 

The first 10 authors by record count

  Author       Institution                        Country         Record count   \%^a^
  ------------ ---------------------------------- --------------- -------------- -------
  Aktories     University of Freiburg             Germany         235            0.94
  Jankovic     Weill Cornell Medical School       United States   172            0.69
  Dressler     Weill Cornell Medical School       Germany         161            0.65
  Johnson      University of Wisconsin--Madison   United States   147            0.59
  Kozaki       Osaka Prefecture University        Japan           139            0.56
  Montecucco   University of Padua                Italy           131            0.53
  Barth        University of Ulm                  Germany         130            0.52
  Popoff       Institute of Pasteur               France          127            0.51
  Oguma        University of Tokyo                Japan           117            0.47
  Bigalke      Toxogen                            Germany         116            0.46

^a^Total documents published in homeopathy literature

###### 

The top 10 institutions by number of publications in literature related to botulinum toxin

  Organizations                                         Document number   \%
  ----------------------------------------------------- ----------------- ------
  University of California System (United States)       708               3
  University of London (United Kingdom)                 649               2.75
  University College London (United Kingdom)            485               2.05
  United States Department of Defense (United States)   416               1.76
  University of Wisconsin System (United States)        398               1.68
  University of Wisconsin Madison (United States)       393               1.66
  United States Army (United States)                    371               1.57
  Harvard University (United States)                    333               1.41
  Hannover Medical School (Germany)                     315               1.33
  University of Toronto (Canada)                        306               1.29

###### 

The first 10 journal source according to the number of published documents

  Journal name                           Number of publications   \%
  -------------------------------------- ------------------------ ------
  *Movement Disorders*                   789                      3.34
  *Neurology*                            491                      2.08
  *Toxicon*                              471                      1.99
  *Dermatologic Surgery*                 353                      1.49
  *European Journal of Neurology*        331                      1.4
  *Journal of Urology*                   319                      1.35
  *Journal of Biological Chemistry*      291                      1.23
  *Plastic and Reconstructive Surgery*   239                      1.01
  *Neurourology and Urodynamics*         232                      0.98
  *Journal of Neurology*                 188                      0.8

Progression of publications and citations and the correlations {#sec2-4}
--------------------------------------------------------------

We performed a citation analysis of the last decade of BoNT literature. In the last decade, a total of 9,555 articles were published in this field. H-index of botulinum toxin literature was measured to be 83. Documents published in BoNT literature were cited 83,376 times (48,233 times without self-citations) in total between 2008 and 2017. Average citations per item was measured to 8.73 times. Peak year for citations was 2017 (*n* = 17,496) \[[Figure 4](#F4){ref-type="fig"}\]. We detected no correlation between publication number and citation number by year (*P* = 0.232). The most cited article in this field was found to be titled "Recommendations for the pharmacological management of neuropathic pain: an overview and literature update" by Dworkin *et al.*\[[@ref5]\] published in *Mayo Clinic Proceedings* cited 592 times (average citations per year: 65.78) \[[Table 6](#T6){ref-type="table"}\].

![Total publication and citation numbers of botulinum toxin articles by year](JCAS-13-95-g004){#F4}

###### 

The 10 most cited manuscripts in botulinum toxin literature

  Article                                                                                                                                                             Author              Journal name/ published                        Total citation   Average citations per year
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------- ---------------------------------------------- ---------------- ----------------------------
  Recommendations for the pharmacological management of neuropathic pain: an overview and literature update                                                           Dworkin *et al.*    *Mayo Clinic Proceedings*                      592              65.78
  Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis                                                                               Finnerup *et al.*   *Lancet Neurology*                             470              117.5
  EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction                            Oelke *et al.*      *European Urology*                             466              77.67
  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial                    Diener *et al.*     *Cephalalgia*                                  343              38.11
  The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the non-motor symptoms of Parkinson's disease                                   Seppi *et al.*      *Movement Disorders*                           341              42.63
  OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial                    Aurora *et al.*     *Cephalalgia*                                  313              34.78
  Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis                                                                             Campos *et al.*     *Annals of Surgery*                            305              30.5
  OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program   Dodick *et al.*     *Headache*                                     294              32.67
  A systematic review of interventions for children with cerebral palsy: state of the evidence                                                                        Novak *et al.*      *Developmental Medicine and Child Neurology*   274              45.67
  Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomized controlled trials           Coombes *et al.*    *Lancet*                                       261              29

Bibliometric network analyses {#sec2-5}
-----------------------------

As we performed a detailed keyword analysis, we found that the most used keywords in this field were "*botulinum toxin*," "*botulinum toxin type a*," "*spasticity*," and "*dystonia*." We noted that the most used keywords were selected from neurological terms. We generated a bibliometric keyword network visualization map in which the keyword of "botulinum toxin" centered with the largest diameter and connected with the other keywords \[[Figure 5](#F5){ref-type="fig"}\]. We created a connection network map of the countries producing documents in this area, and this bibliometric network revealed seven main centers including the United States, Germany, United Kingdom, Italy, Canada, France, and Japan. Institutional bibliometric network showed connections between medical organizations and the companies producing commercial BoNT products \[[Figure 6](#F6){ref-type="fig"}\].

![Keyword network of botulinum toxin literature](JCAS-13-95-g005){#F5}

![Institutional network of botulinum toxin literature](JCAS-13-95-g006){#F6}

Indian contribution to the literature {#sec2-6}
-------------------------------------

Although Indian population is equivalent to 17.71% of the total world population, it produced only 0.83% of all botulinum toxin literature (*n* = 207 articles). The most common document type was original article (64.368%) followed by review, letter, and meeting abstract (21.839%, 5.747%, and 4.598%, respectively). The most prolific Indian author was Dhaked from Biotechnology Division, Defence Research and Development Establishment, with 10 articles. Defence Research and Development Establishment was also the most productive institution of the Indian literature with 17 documents. *Annals of Indian Academy of Neurology* was the most productive source title with seven items. H-index of Indian literature was measured as 20 and total number of citations was 1760 (1719 without self-citations). The most cited manuscript was a review titled "Drooling in Parkinson's disease: a review" written by Srivanitchapoom *et al.*\[[@ref6]\] published in 2014. This article has been cited 123 times in total.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Botulinum toxin serotypes inhibit neurotransmitter release from nerve terminals and prevent acetylcholine release at the neuromuscular junction. Seven different types of BoNT titled from BoNT A through BoNT G have been identified so far. An eighth serotype named BoNT X has been reported more recently but no product of this serotype has been produced yet.\[[@ref7]\] Although *Clostridium botulinum* is the organism for the production of BoNT, some companies have been exploring the use of recombinant expression of *Escherichia coli*.\[[@ref8]\] Generated infographic of institutional bibliometric map revealed a cooperative network of the companies producing publications in BoNT literature \[[Figure 6](#F6){ref-type="fig"}\].

Bibliometrics is a novel and popular scientific field investigating academic literature and analyzing publication trends and patterns in a certain area.\[[@ref9]\] Although an expanding and high demand across the world has been reported in noninvasive cosmetic treatment solutions such as botulinum toxin, to the best of our knowledge, there has been no study investigating bibliometric features of botulinum toxin literature.\[[@ref10]\] Thus, the only limitation of our article was that there was no study to compare our results within the literature.

Today, the cosmetic use of BoNT has been reported to be the most common aesthetic procedure performed throughout the world.\[[@ref11]\] Current common aesthetic applications of BoNT include treatment of forehead wrinkles and glabellar, periorbital, perioral, and horizontal neck lines. In 2015, the members of American Society of Dermatologic Surgery (ASDS) performed approximately 10 million treatments and BoNT A was used in 1.8 million of which. The net revenue of BoNT A application in aesthetic indications reached \$199.4 million in 2016 and according to the American Society of Plastic Surgeons, a total of 15.4 million aesthetic procedures were performed during 2016 and in 7 million of which BoNT A was used.\[[@ref12]\] According to 2017 report of ASDS, nearly 12 million cosmetic procedures were performed and BoNT A was applied in 2.1 million of which.\[[@ref13]\] In the United States, three BoNT A formulations are available for aesthetic applications although specific aesthetic versions of BoNT A are on market in the European Union. BoNT B is also available for neurological conditions and it is not yet approved for aesthetic indications.\[[@ref14][@ref15]\] Use of BoNT A has been rising for the last decades cosmetically and therapeutically, and the global market for BoNT A is estimated to reach approximately \$7.4 billion by 2024.\[[@ref10]\] Although the products of botulinum toxin are known to have been used only cosmetically and aesthetically, we found that the most searched area in BoNT literature is neuroscience. However, we noted that BoNT A has been studied much more than BoNT B and even BoNT B was not one of the most common 20 keywords \[[Figure 5](#F5){ref-type="fig"}\]. We detected that all authors and institutions in the top 10 productive lists were from developed countries. The United States was reported to represent the largest market worldwide, and we found that US Department of Defense and US Army were in top 10 institutions reporting researches investigating botulinum toxin (1.76 and 1.57, relatively) \[[Table 4](#T4){ref-type="table"}\] supported by approvals for the application in novel therapeutic indications.\[[@ref10]\]

Although the dose units are specific for each BoNT A product family, we detected that differences of BoNT A products were not included in the most studied areas, and the brand names of BoNT A were not in the most used keywords list \[[Figure 5](#F5){ref-type="fig"}\].

C[ONCLUSIONS]{.smallcaps} {#sec1-5}
=========================

Botulinum toxin has been reported to be the most poisonous substance known and it can be used as a biological weapon. Even a single gram toxin of a crystalline toxin inhaled would kill more than one million people.\[[@ref16][@ref17]\] Therefore, more studies investigating botulinum toxin and bioterrorism should be carried out. We suggest that researchers from developing and least-developed countries should be funded and encouraged to perform novel studies, particularly on BoNT B.
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